// App-Quantinova.ai

[OP0036] : FEWER PATIENTS ON BIOLOGICALS AND BETTER FUNCTIONAL ABILITY TWO YEARS AFTER INDUCTION THERAPY WITH COMBINATION DMARD THERAPY VERSUS METHOTREXATE MONOTHERAPY

Researchers

Presenter

  • M. Kuijper

Principal Investigators

  • A. Weel

  • P. de Jong

  • A. Gerards

  • J. van Zeben

  • I. Tchetverikov

  • P. de Sonnaville

  • M. van Krugten

  • B. Grillet

  • M. Hazes

  • J. Luime

Medical Centers

  • Rheumatology, ZorgSaam Hospital, Terneuzen, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

  • Sulfasalazine

  • Methotrexate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved